Highlights • Initial trial results examining the efficacy of adjuvant immune checkpoint inhibitors in the setting of high-risk, resected muscle invasive urothelial carcinoma provided disparate results. • In this systematic…
Highlights • High grade and very high grade NMIBC has the potential to reoccur and progress and the BCG intravesical therapy is an adjuvant gold standard treatment. • Smoking impacts…
Highlights • The carcinogenic pathways of heavy metals/ trace elements in bladder cancer are studied. • They include alterations in MD, OS/ROS, and p38-MAPK pathway. • This data provides a…
Highlight • Neoadjuvant therapy significantly improved DFS and OS in RCC patients with IVC thrombus. • Patients receiving neoadjuvant therapy had a 2-year recurrence-free survival of 70.9%. • Pathological complete…
Highlights • Partial cystectomy serves as a less invasive alternative for muscle-invasive bladder cancer. • The 5-year Overall Survival rate was 55%, Cancer Specific Survival was 67%, and Recurrence-Free Survival…
Highlights • Prostate cancer is associated with the genetic components. • The understanding of the genetics components of prostate cancer will help researchers in developing mitigating approach. • GWAS provides…
Abstract Over the years, several imaging techniques have been used in the diagnosis and management of testicular cancer. We compartmentalize disease stages into preorchiectomy, stage 1, initial stage 2 and…
Highlights • Accounting for postprogression therapies improves overall survival (OS) estimation. • Multistage treatment strategies (MTS) guide treatment sequence decisions to optimize OS. • Sequentially Multiple Assignment Randomized Trials (SMART)…
Highlights • A prospective study to validate the diagnostic performance of CRiSS in SCC penis. • CRiSS can avoid ILND with a zero false negative rate, irrespective of cN status….
Highlights • The addition of androgen receptor signaling inhibitors (ARSIs) to androgen deprivation therapy (ADT), known as ARSI doublet therapy, has shown a significant impact on PSA dynamics and oncological…
